What's in a name?
Alex WhiteHead of ResearchAsset & Liability Management
Find me on LinkedIn
“What’s in a name? That which we call [risk] by any other name would [cause a headache].”
Admittedly, I don’t think Shakespeare could ever have imagined his famous words being shoehorned into an article about types of fund risk ratings. But in this case, there’s a lot in a name. Does ‘risk’ mean volatility? Is it backward-looking or forward-looking? Is it Value at Risk? Or is it based on historical stress tests? You get the picture; there’s much at play beneath the umbrella term.
For LGPS funds, risk is a crucial consideration in investment decision-making. But the type of risk metric used and the extent to which it drives decision-making can make a material difference to outcomes. It’s essential to consider – and manage – fund risks to avoid being blown off track.
Suppose the chosen risk metric is 3-year rolling volatility, and a manager is buying high-yield bonds. The overall volatility since 1999 has been 10-11%, so let’s suppose the manager will reduce their allocation when rolling volatility reaches 12% – what would that have done to performance? Left alone, excess returns on the index were 4.1%; but by reducing allocations after a fall (i.e., when spreads were higher), the returns fall to 3.2%, losing 0.9% a year, or c.20% of the returns. And while the risk is lower (9.4% against 10.3%), the difference in the risk reduction is smaller than the returns lost and the Sharpe ratio is worse.
The following table highlights some of the trade-offs involved with different metrics. What jumps out is that all metrics have plenty of flaws, so the best way to build a robust portfolio is to use multiple.
At Redington, we typically start with Value at Risk (VaR). This is a statistic that quantifies the possible losses within a portfolio or position over a specific timeframe. Our calculation measures the loss that would be incurred in a worst-case scenario over the next year; the worst case is often assumed to be a 1-in-20 event (VaR 95). We think it’s critical to look at this alongside other risk lenses like stress tests, sensitivity analysis and long-term projections.
Look deeper at your chosen methodology, challenge the assumptions and, if you need any help determining “what’s in a name” when it comes to your portfolios and outcomes, we’re here to help.